Hard to Overlook Longhai Steel and $608 Million in Revenue in 2011

Longhai Steel (LGHS)

Scrolling through another batch of earnings reports from big board companies in the steel business once again showcases the out of sync valuation with Longhai Steel, Inc. (OTCBB: LGHS) and its industry peers.

Olympic Steel, Inc., (NASDAQ: ZEUS) reported net sales for the fourth quarter of 2011 totaled $319.9 million, the highest ever for a fourth quarter, and increased 48.7% from $215.2 million for the fourth quarter of 2010. Fourth quarter 2011 net income totaled $0.6 million, or $0.05 per diluted share, compared to a net loss of $1.6 million, or $0.15 per diluted share, in last year’s fourth quarter.  Net sales for the year totaled $1.26 billion in 2011, a record annual revenue total, and increased 56.7% from $805 million in 2010. For 2011, net income increased by $22.9 million to $25.0 million, or $2.28 per diluted share, compared to net income of $2.1 million, or $0.20 per diluted share, for 2010.  Shares are trading around $24 each with a market cap of $260 million.

China Gerui Advanced Materials Group Ltd. (NASDAQ:CHOP) reported 2011 Q3 revenue of $101.1 million as compared to $61.9 million in the same quarter of 2010.  Gross profit for the quarter was reported at $32.1 million; up from $18.6 million in the 2011 quarter.  Operating income increased to $28.7 million from $16.5 million.  The company was recently upgraded to NASDAQ Global Select.  China Gerui has no long-term debt, but more than $216 million in short-term debt.  Shares are trading at $3.57 with a $210 million market cap.

Schnitzer Steel Industries (NASDAQ:SCHN) said that it expects fully diluted earnings per share for the second quarter to be approximately $0.28 - $0.35.  It reports its earnings on April 5th.  Shares are trading at $40 with a market cap of $1.1 billion.

For its third quarter ended Feb. 29, 2012, Worthington Industries (NYSE: WOR) reported a profit of $25.9 million, or 37 cents a share, down from $26.3 million, or 35 cents a share, a year earlier on a revenue increase of 7.3% to $611.3 million.  Revenue at Worthington’s steel processing business, its biggest by sales, rose 22% to $367.3 million.  Shares are trading at $19 each with a market cap of $1.33 billion.

The unsung hero in this business looks to be Longhai Steel Inc. (OTCBB: LGHS), a producer of high-quality steel wire products in the People’s Republic of China.  Today, the company announced financial results for the year ended December 31, 2011 which included steel wire sales revenue of $608 million compared with revenues of $475 million for 2010, an increase of $133 million, or 28 percent.  For 2011 gross profit rang-in at $18.7 million compared to gross profit of $18.6 million for 2010.  2011 net income was $11.2 million, or $1.12 per fully diluted share, compared with net income of $11.3 million for 2010.

At December 31, 2011, shareholder’s equity equaled $57.5 million, or $5.72 per fully diluted share.  Longhai has no long-term debt.  Shares are trading at $1.48 each with a market cap of $14.8 million.

We first compared Longhai to peers in a February article when shares were at the $1 mark.  Shares have risen in value, but this company still seems to have a tremendous upside to get on par in valuation with others in the industry.  The new plant getting fully online could potentially send annual sales near the $1 billion mark.

Mr. Steven Ross, Executive Vice President of Longhai, said in today’s release, “We are pleased to report record sales for 2011, largely driven by the opening of our new production facility in the fourth quarter of 2011. As the newly-opened steel wire facility continues to ramp output, we expect to see continued year-over-year improvements in operating results throughout 2012. During the first quarter of 2012 we also reconstituted our Board of Directors and transitioned to a new auditing firm, Marcum Bernstein & Pinchuk, LLP, both significant steps toward our goal of moving to a senior exchange.”

Ross continued, “Once fully ramped, the new facility will increase our overall capacity by approximately 60%, and have the capability to produce such high margin products as alloy steel, cold forging steel and welding rods. Over the next two quarters we expect to begin utilizing higher quality steel billets, which will enable us to produce higher quality and higher margin products for additional markets beyond construction and infrastructure.”

Longhai Steel (LGHS) Stock Quote and News:

Disclaimer: Neither nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at


Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Andes Gold Corp. Stock Chart Analysis Video

Andes Gold Corp. Stock Chart Analysis Video(0)

The stock chart for Andes Gold Corporation (Pink Sheets: AGCZ) is in a solid uptrend in 2012; moving from a penny to touch $0.068 in the past two months.  Both the 50 and 200 day simple moving averages are trending upward with the pps holding well above those key markers.  Support is established at $0.05

Stocks Slip at Open on Fourth Quarter GDP

Stocks Slip at Open on Fourth Quarter GDP(0)

The U.S. economy expanded in the fourth quarter of 2011 basically right in line with economists’ predictions.  In the Commerce Department’s final estimate released this morning, gross domestic product (GDP) increased at a 3.0 percent annual rate in the final quarter after a 1.8 percent growth rate during the third quarter.  This is the fastest

Salamon Group Lands New Solar Projects

Salamon Group Lands New Solar Projects(0)

Solar energy company Salamon Group, Inc. (OTCQB: SLMU) reported that it secured the rights to build solar power systems on the rooftops of 23 schools in Williamson County Tennessee.   The Las Vegas-based company will immediately start building 3 solar power systems with an output of 200 kilowatts each, which will equate to $3.3 million in

Optimer and Astellas Partner on Clostridium Difficile Infection Drug

Optimer and Astellas Partner on Clostridium Difficile Infection Drug(0)

San Diego, California-based Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Tokyo-based Astelllas Pharma Inc. (Pink Sheets: ALPMY, Tokyo: 4503) reported this morning that the execution of an exclusive collaboration and license agreement to develop and commercialize fidaxomicin tablets in Japan for the treatment of Clostridium difficile Infection (CDI). Fidaxomicin is approved by the U.S. Food and

ChromaDex Launches Aggressive Marketing Campaign for BluScience

ChromaDex Launches Aggressive Marketing Campaign for BluScience(0)

A new multi-million national media campaign has been launched by Irvine, California’s ChromaDex Corporation (OTCBB:CDXC) for its recently commercialized BluScience™ line of dietary supplements.  The help facilitate the media blitz – which will include television, radio and digital outlets - ChromaDex has retained RJ Palmer, a NYC-based full service media agency with billings in excess

read more

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.